<p>Horizontal bars represent the estimated net effect on cost per cancer prevented in US Dollars with a 1% increase in the listed parameters.</p
<p>Net cost per cancer prevented (US dollars) for each strategy at varying prevalence rates of <i>H....
<p>The sensitivity analysis recalculates the net expected cost of each strategy (Scr vs. uNGAL+Scr),...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen if 30-day mortalit...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen screening with tre...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 5%.<...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 15%....
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen testing cost of $6...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen testing cost of $2...
<p>Each horizontal bar represents the full range of cost-effectiveness ratios produced by varying a ...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen if 30-day mortalit...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen if 30-day mortalit...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen if 30-day mortalit...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen screening with tre...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen if 30-day mortalit...
<p>Sensitivity analysis of the influence of C vs. T in overall cancer meta–analysis (fixed–effects e...
<p>Net cost per cancer prevented (US dollars) for each strategy at varying prevalence rates of <i>H....
<p>The sensitivity analysis recalculates the net expected cost of each strategy (Scr vs. uNGAL+Scr),...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen if 30-day mortalit...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen screening with tre...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 5%.<...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 15%....
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen testing cost of $6...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen testing cost of $2...
<p>Each horizontal bar represents the full range of cost-effectiveness ratios produced by varying a ...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen if 30-day mortalit...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen if 30-day mortalit...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen if 30-day mortalit...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen screening with tre...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen if 30-day mortalit...
<p>Sensitivity analysis of the influence of C vs. T in overall cancer meta–analysis (fixed–effects e...
<p>Net cost per cancer prevented (US dollars) for each strategy at varying prevalence rates of <i>H....
<p>The sensitivity analysis recalculates the net expected cost of each strategy (Scr vs. uNGAL+Scr),...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen if 30-day mortalit...